☰

Reem Malek, Ph.D. - Publications

Affiliations: 
2013 Basic Medical Sciences Purdue University, West Lafayette, IN, United States 
Area:
Cell Biology, Oncology, Human Development
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya MA, Wang X, Simons BW, Ballew M, Nugent K, Groves J, Williams RD, Shiraishi T, Verdone J, Yildirir G, Henry R, et al. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. The Journal of Clinical Investigation. PMID 30130254 DOI: 10.1172/Jci94844  0.315
2017 Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, et al. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment. Oncogene. PMID 28869602 DOI: 10.1038/Onc.2017.308  0.32
2017 Malek R, Gajula RP, Williams RD, Nghiem B, Simons BW, Nugent K, Wang H, Taparra K, Lemtiri-Chlieh G, Yoon AR, True L, An SS, DeWeese TL, Ross AE, Schaeffer EM, et al. TWIST1-WDR5-Hottip regulates Hoxa9 chromatin to facilitate prostate cancer metastasis. Cancer Research. PMID 28484075 DOI: 10.1158/0008-5472.Can-16-2797  0.354
2017 Malek R, Wang H, Taparra K, Tran PT. Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition. Cells, Tissues, Organs. 203: 114-127. PMID 28214899 DOI: 10.1159/000447238  0.393
2016 Taparra KT, Wang H, Malek R, Nugent K, Groves J, Yildirir G, Simons B, Felsher D, Zachara N, Tran PT. SNAI1 Regulates the Hexosamine Biosynthesis Pathway to Promote Kras Mutant Lung Tumorigenesis. International Journal of Radiation Oncology, Biology, Physics. 96: S54-S55. PMID 27675956 DOI: 10.1016/J.Ijrobp.2016.06.142  0.326
2016 Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, Malek R, Gabrielson KL, Van Diest PJ, Tran PT, Raman V. RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3. Cancer Research. PMID 27634756 DOI: 10.1158/0008-5472.Can-16-0440  0.316
2016 Chettiar ST, Malek R, Annadanam A, Nugent KM, Kato Y, Wang H, Cades JA, Taparra K, Belcaid Z, Ballew M, Manmiller S, Proia D, Lim M, Anders RA, Herman JM, et al. Ganetespib radiosensitization for liver cancer therapy. Cancer Biology & Therapy. 0. PMID 26980196 DOI: 10.1080/15384047.2016.1156258  0.371
2016 Taparra K, Wang H, Nugent K, Malek R, Groves J, Yildirir G, Simons B, Felsher D, Zachara N, Tran P. Abstract 1054: SNAI1 regulates the hexosamine biosynthetic pathway to promote tumorigenesis and oncogene-induced senescence escape in lung cancer Cancer Research. 76: 1054-1054. DOI: 10.1158/1538-7445.Am2016-1054  0.449
2015 Gajula RP, Chettiar ST, Williams RD, Nugent K, Kato Y, Wang H, Malek R, Taparra K, Cades J, Annadanam A, Yoon AR, Fertig E, Firulli BA, Mazzacurati L, Burns TF, et al. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells. Neoplasia (New York, N.Y.). 17: 16-31. PMID 25622896 DOI: 10.1016/J.Neo.2014.10.009  0.372
2014 Mendrysa SM, Malek R. Abstract B16: Dissecting MDM2 function in medulloblastoma pathogenesis Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-B16  0.741
2014 Walker AJ, Nirscle CJ, Nugent K, Nirschle TR, Harris TJ, Wang H, Sharabi AB, Velerde E, Malek R, Williams R, Cades J, Taparra K, Gajula R, Herman JM, Wong JW, et al. Combining Checkpoint Blockade With Radiation Therapy Results in Tumor and Immunological Responses in an Autochthonous Mouse Model of Lung Cancer : Translational Research International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.302  0.319
2014 Walker A, Nirscle C, Nugent K, Nirschle T, Harris T, Wang H, Sharabi A, Velerde E, Malek R, Williams R, Cades J, Taparra K, Gajula R, Herman J, Wong J, et al. Combining Checkpoint Blockade With Radiation Therapy Results in Tumor and Immunological Responses in an Autochthonous Mouse Model of Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 90: S70. DOI: 10.1016/J.Ijrobp.2014.05.199  0.32
2012 Wang G, Fulkerson CM, Malek R, Ghassemifar S, Snyder PW, Mendrysa SM. Mutations in Lyar and p53 are synergistically lethal in female mice. Birth Defects Research. Part a, Clinical and Molecular Teratology. 94: 729-37. PMID 22815056 DOI: 10.1002/Bdra.23048  0.687
2012 Malek R, Taylor N, Mendrysa SM. Abstract 5213: MDM2 at the crossroads of cell fate decisions in cerebellar development and medulloblastoma Cancer Research. 72: 5213-5213. DOI: 10.1158/1538-7445.Am2012-5213  0.742
2011 McGowan KA, Pang WW, Bhardwaj R, Perez MG, Pluvinage JV, Glader BE, Malek R, Mendrysa SM, Weissman IL, Park CY, Barsh GS. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 118: 3622-33. PMID 21788341 DOI: 10.1182/Blood-2010-11-318584  0.667
2011 Mendrysa SM, Ghassemifar S, Malek R. p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer. Genes & Cancer. 2: 431-42. PMID 21779511 DOI: 10.1177/1947601911409736  0.716
2011 Malek R, Matta J, Taylor N, Perry ME, Mendrysa SM. The p53 inhibitor MDM2 facilitates Sonic hedgehog-mediated tumorigenesis and influences cerebellar foliation Plos One. 6. PMID 21437245 DOI: 10.1371/Journal.Pone.0017884  0.732
Show low-probability matches.